Resource impact information

Following the publication of NICE's technology appraisal guidance on empagliflozin for treating symptomatic chronic heart failure with reduced ejection fraction in adults, a new local resource impact template has been published to include all current NICE recommended treatments for this patient group.

This page was last updated: